Also trades as: 0R1F.L (LSE) · $vol 1M · 0R1F.IL (IOB) · $vol 1M · BRM.DE (XETRA) · $vol 0M · BMY.SW (SIX) · $vol 0M
BMY NYSE
Bristol-Myers Squibb Company
1W: -0.2%
1M: -2.6%
3M: -1.4%
YTD: +18.9%
1Y: +46.8%
3Y: +25.6%
5Y: +31.5%
$61.55
-0.06 (-0.10%)
Weekly Expected Move ±5.2%
$55
$58
$61
$65
$68
Credit Risk of going bust: lower than 72% of companies Debt: 25.5% of company value Bonds: $498.7M held by 336 funds, 76 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.26 (down 98%), Bristol-Myers Squibb Company would be worth roughly what it owes.
Total debt $43.12B against a stock market value of $125.73B.
Distance to default 7.91 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $22.07B (short-term plus half of long-term), stock volatility 28.2%; Altman Z 2.67. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.26 (down 98%), Bristol-Myers Squibb Company would be worth roughly what it owes.
Total debt $43.12B against a stock market value of $125.73B.
Distance to default 7.91 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $22.07B (short-term plus half of long-term), stock volatility 28.2%; Altman Z 2.67. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.36
Bullish
2 bullish
3 neutral
0 bearish
Articles (24h)
5
Hourly Sentiment (24h)
Articles (5)
Anthropic acquires single-employee rare disease drug developer
What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?
8,656 Bristol Myers Squibb Company $BMY Shares Sold by Evergreen Capital Management LLC
Bristol Myers Squibb’s Cancer Drug Just Doubled Survival Time Without Progression — Here’s Why It Matters
0.22
Neutral
10 bullish
15 neutral
3 bearish
Articles (7d)
28
Daily Sentiment (7 Days)
Articles (100)
Anthropic acquires single-employee rare disease drug developer
What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?
8,656 Bristol Myers Squibb Company $BMY Shares Sold by Evergreen Capital Management LLC
Bristol Myers Squibb’s Cancer Drug Just Doubled Survival Time Without Progression — Here’s Why It Matters
Moderna CEO Bancel sees other cancer indications for melanoma vaccine
3 Cheap Dividend Stocks I'd Buy Without Any Hesitation
Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?
Bristol Myers Squibb: Bargain Buy or Value Trap?
Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stock
Bristol Myers (BMY) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
3 High-Yield Stocks to Buy With $1,000 Right Now
Citizens Financial Group Inc. RI Buys 44,768 Shares of Bristol Myers Squibb Company $BMY
Roche lung cancer drug extends survival by nearly six months in late-stage trial
Should You Buy Bristol Myers Squibb While It Trades Below 10 Times Forward Earnings?
Earnings Week Ahead: MSFT, GOOGL, AMZN, XOM, BA, VZ, and more
Bristol, Tempus AI partnering with Pathos AI to advance neurological treatments
Bristol Myers Squibb (BMY) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Bristol reports patient death in early trial of CAR-T therapy for multiple sclerosis
BMY vs. ABBV: Which Pharma/Biotech Stock Offers More Upside Potential?
Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?
Bristol Myers Squibb vs. Pfizer: Consistency vs. Scale in Revenue
BioNTech to investigate pumitamig in combination with Gilead's Trodelvy
Earnings Preview: Bristol Myers Squibb (BMY) Q3 Earnings Expected to Decline
Bristol Myers Squibb vs. Novo Nordisk: Stable Scale vs. GLP-1 Volatility
Bristol Myers Squibb vs. Eli Lilly: How Long Can Zepbound and Mounjaro Keep Juicing Revenue Results?
AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue?
Can BMY Navigate Generic Challenges Across Its Key Drug Portfolio?
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
Prothena's Partnership Strategy: Growth Driver or Limitation?
Have $1,000 to Invest? This Dirt Cheap Pharma Stock Pays You 4.2% to Wait.
Pfizer's Non-Oncology Performance in Q3: Driving Factors to Watch
Can Myqorzo's Expansion and Growing Adoption Drive CYTK's Growth?
Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy?
Birch Hill Investment Advisors LLC Acquires 160,411 Shares of Bristol Myers Squibb Company $BMY
Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
Can Gilead's Deal With VIR Boost Its Oncology Pipeline and Growth?
Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Bristol Myers Squibb vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
BMY Reports Mixed Phase III Trial Results, Stock Down
Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today
Bristol down as Street reacts to admilparant results in IPF
BMY Surges 35.7% in a Year: Should You Buy, Sell or Hold the Stock?
4 stocks to watch on Monday: ADBE, TMUS, CRM, and BMY
Bristol Myers jumps as two late-stage trials deliver positive results
Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends?
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Hospital group files lawsuit to stop 340B rebate pilot again
20,370 Bristol Myers Squibb Company $BMY Shares Bought by Apella Capital LLC
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Roche taps Chinese startup for drug discovery
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
AbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in Cancer
Bristol Myers posts late-stage trial win for multiple myeloma therapy Zenbexus
2 High-Yield Stocks to Buy in October (Hint: Bristol Myers Squibb Is One)
Can Reblozyl Power Bristol Myers' Top-Line Growth Going Forward?
Pharma lobby group sues Trump administration over MFN pricing
Can Redwire's Microgravity Pharma Work Create New Revenue Streams?
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
Zacks.com featured highlights Dollar General, Bristol-Myers Squibb and Equinor ASA
AstraZeneca CEO Soriot says drugmaker can grow without big acquisition
BMY or ARGX: Which Is the Better Value Stock Right Now?
Are Investors Undervaluing Bristol Myers Squibb (BMY) Right Now?
3 Stocks With Broker Rating Upgrades Amid Resilient Equity Markets
3 Dirt Cheap Dividend Stocks Worth Buying in October
AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot
CX Institutional Sells 208,135 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Now Trades at Only 9.4X Forward Earnings -- Is This Value Stock a Buy?
Agios' Growth Story Hinges on Mitapivat's Commercial Expansion
Will Camzyos Growth Keep Driving BMY's Cardiovascular Portfolio?
Medicare drug pricing model to affect only four firms after Trump’s MFN policy
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
Bristol-Myers Squibb vs. Johnson & Johnson: Comparing Quarterly Revenue Scale
FDA launches recruitment drive to add members to advisory panels
Bristol wins approval of Camzyos for children with rare heart condition
Pharmaceutical industry lobbying group names new CEO, Eric Cantor
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
Bristol Myers Squibb vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?
Potential liver safety issue seen in phase 3 trial for Bristol's admilparant
Here Are My Top 2 High-Yield Healthcare Stocks to Buy Now
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
3 Numbers That Explain Bristol Myers Squibb's Dirt Cheap Valuation
Lexicon a new overweight at Cantor on optimism for Inpefa in cardiomyopathy
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Kevin Warsh Just Signaled Higher-for-Longer Rates. Here's What That Means for Big Pharma Dividend Stocks.
Top Stock Reports for Tesla, Bank of America & Coca-Cola
FDA commissioner nominee Overton rebuffs questions about Trump medical claims
Why Women-Run Companies Deserve a Place in Your Portfolio
Can Recent Traction With Key Drugs and Pipeline Progress Boost BMY?
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Bristol Myers Squibb and Johnson & Johnson Both Face Challenges Ahead: Which Healthcare Stock Looks More Resilient Now?
QRG Capital Management Inc. Purchases 14,906 Shares of Bristol Myers Squibb Company $BMY
New Strong Buy Stocks for September 24th
Best Income Stocks to Buy for September 24th
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Merck says FDA approved label update for PAH therapy Winrevair
BMY vs GILD: Which Biotech Stock Looks More Attractive Now?
Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term